GlassScriptPhysician profile
Eric J Fryer
NPI 1497856751
$1,717.78
in general payments reported to CMS, 2019-2025
20 companies · $426 in 2025
The $426 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.09 · 2020: $142 · 2021: $91.46 · 2022: $254 · 2023: $161 · 2024: $587 · 2025: $426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,159 · Education: $15.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,159.09 |
| Education | $15.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $622.92 | 2021-2025 | Opzelura |
| Dermavant Sciences, INC. | $189.19 | 2023-2024 | Vtama |
| Arcutis Biotherapeutics, INC. | $175.42 | 2024-2025 | Zoryve |
| Amgen INC. | $109.14 | 2019-2024 | Otezla |
| E.R. Squibb & Sons, L.L.C. | $79.55 | 2022-2024 | Sotyktu |
| Galderma Laboratories, L.P. | $66.86 | 2020-2023 | Oracea, Aklief |
| Sun Pharmaceutical Industries INC. | $62.46 | 2021-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $53.20 | 2020 | |
| Vyne Pharmaceuticals INC. | $53.00 | 2020 | |
| Mayne Pharma Commercial LLC | $48.89 | 2023-2025 | |
| Pfizer INC. | $44.30 | 2019-2024 | |
| Almirall LLC | $40.65 | 2021-2025 | Seysara |
| Janssen Biotech, INC. | $36.98 | 2022-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $35.61 | 2020-2025 | Dupixent |
| Organon LLC | $23.02 | 2025 | Vtama |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $20.09 | 2025 | |
| Melinta Therapeutics, LLC | $14.88 | 2019 | |
| Leo Pharma INC. | $14.54 | 2021 | |
| Genzyme Corporation | $13.94 | 2025 | |
| Celgene Corporation | $13.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Fryer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.